Updated:
HiMed Angle Fund Management
HiMed Angle Fund Management: Shanghai-based private equity firm investing in early-stage Chinese digital health, biotech, and medical device startups.
HiMed Angle Fund Management
HiMed Angle Fund Management is a private equity firm based in Shanghai, China. It focuses on venture capital investments. The firm has a team of 7 employees.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Sector focus
Frequently asked questions
What investment stages does HiMed Angle Fund Management target?
HiMed Angle Fund Management targets early-stage companies, specifically seed and startup rounds. Its focus is on pre-revenue or early-commercialization ventures in life sciences and digital health (public record).
Does HiMed Angle Fund Management invest outside of China?
Based on available information, HiMed Angle Fund Management appears to invest exclusively in domestic Chinese companies. Its geographic footprint is limited to China, with headquarters in Shanghai.
Which sectors does HiMed Angle Fund Management avoid?
HiMed Angle Fund Management does not publicly state explicit avoidance sectors, but its focus on healthcare and life sciences suggests it avoids technology sectors like fintech, enterprise software, and consumer internet.
Is HiMed Angle Fund Management structured as a single family office or an asset manager?
HiMed Angle Fund Management is structured as a private equity asset manager, not a family office. It is a fund management entity that pools capital from external investors for early-stage healthcare investments (public record).
How does HiMed Angle Fund Management source proprietary deal flow?
HiMed Angle Fund Management likely sources deal flow through relationships with Chinese research institutions, hospitals, and life sciences incubators. However, no specific sourcing model is publicly disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: